Cargando…

Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China

BACKGROUND: In-stent restenosis (ISR) remains a challenge for coronary artery disease (CAD) patients who undergo percutaneous coronary intervention (PCI) with stents, and risk factors for ISR are controversial. This study aimed to investigate the incidence and risk factors of ISR in patients from so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingrui, Hou, Jingyuan, Gu, Xiaodong, Weng, Ruiqiang, Zhong, Zhixiong, Liu, Sudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783476/ https://www.ncbi.nlm.nih.gov/pubmed/35065663 http://dx.doi.org/10.1186/s40001-022-00640-z

Ejemplares similares

Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes
por: Weng, Ruiqiang, et al.
Publicado: (2021)

Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case‐control study
por: Liu, Sudong, et al.
Publicado: (2021)

Characterization of LncRNA expression profile and identification of functional LncRNAs associated with unstable angina
por: Liu, Sudong, et al.
Publicado: (2021)

Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach
por: Hou, Jingyuan, et al.
Publicado: (2022)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Positivity and prevalence of human papillomavirus among a large population of women in southeastern China
por: Liu, Sudong, et al.
Publicado: (2019)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Comprehensive analysis of T-cell receptor repertoire in patients with acute coronary syndrome by high-throughput sequencing
por: Liu, Sudong, et al.
Publicado: (2020)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
por: Hou, Ling, et al.
Publicado: (2023)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations
por: Gu, Xiaodong, et al.
Publicado: (2019)

Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
por: Liu, Sudong, et al.
Publicado: (2019)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
por: Joo, Hyung Joon, et al.
Publicado: (2018)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Risk factors associated with intra-stent restenosis after percutaneous coronary intervention
por: Alexandrescu, Dan-Mihai, et al.
Publicado: (2021)

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways
por: Pelliccia, Francesco, et al.
Publicado: (2023)

Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China
por: Zhao, Pingsen, et al.
Publicado: (2018)

Prevalence of risk factors associated with rupture of abdominal aortic aneurysm (AAA): a single center retrospective study
por: Liu, Sudong, et al.
Publicado: (2023)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do
por: Wang, Pengfei, et al.
Publicado: (2020)

Calculating the overall risk of within-stent restenosis after multilesion percutaneous coronary intervention
por: Parviz, Yasir, et al.
Publicado: (2013)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention: Retraction
Publicado: (2020)

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
por: Zheng, Guo-Hua, et al.
Publicado: (2012)

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
por: Prskalo, Zrinko, et al.
Publicado: (2016)

Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina
por: Liu, Sudong, et al.
Publicado: (2020)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
por: Zhang, Rui, et al.
Publicado: (2022)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention
por: Sun, Lin, et al.
Publicado: (2019)

SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention
por: Zhou, Liang, et al.
Publicado: (2017)

Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention
por: He, Wenbo, et al.
Publicado: (2021)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
por: Elbadawi, Ayman, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor Genetic Variant Is Associated with in-Stent Restenosis after Percutaneous Coronary Intervention
por: Asgarbeik, Saeedeh, et al.
Publicado: (2022)

Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China
por: Zhong, Zhixiong, et al.
Publicado: (2017)

Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
por: Liu, Sudong, et al.
Publicado: (2021)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1afaqvcg5eocrbhrlkuriuvg3a